Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000078003-26-000054
Filing Date
2026-05-05
Accepted
2026-05-05 07:03:03
Documents
94
Period of Report
2026-03-29

Document Format Files

Seq Description Document Type Size
1 10-Q pfe-20260329.htm   iXBRL 10-Q 2081412
2 EX-10.1 pfe-exh101x3292026x10q.htm EX-10.1 150196
3 EX-31.1 pfe-exh311x3292026x10q.htm EX-31.1 8959
4 EX-31.2 pfe-exh312x3292026x10q.htm EX-31.2 8951
5 EX-32.1 pfe-exh321x3292026x10q.htm EX-32.1 4464
6 EX-32.2 pfe-exh322x3292026x10q.htm EX-32.2 4445
  Complete submission text file 0000078003-26-000054.txt   12526053

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pfe-20260329.xsd EX-101.SCH 81411
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pfe-20260329_cal.xml EX-101.CAL 155155
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pfe-20260329_def.xml EX-101.DEF 378694
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pfe-20260329_lab.xml EX-101.LAB 888839
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pfe-20260329_pre.xml EX-101.PRE 621930
98 EXTRACTED XBRL INSTANCE DOCUMENT pfe-20260329_htm.xml XML 2442840
Mailing Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192
Business Address 66 HUDSON BOULEVARD EAST NEW YORK NY 10001-2192 2127332323
PFIZER INC (Filer) CIK: 0000078003 (see all company filings)

EIN.: 135315170 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-03619 | Film No.: 26940380
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)